Streetbeat News

Analyst Ratings

ATMU

Atmus Filtration Techs (NYSE:ATMU) has received 7 bullish and somewhat bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the stock, according to 7 analysts, is $26.57, up 2.19% from the previous average of $26.00.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

DNLI

Denali Therapeutics (NASDAQ:DNLI) has received positive analyst ratings in the last quarter, with 2 bullish and 4 somewhat bullish ratings. The average price target for the stock is $79.83, a significant increase from the previous average of $53.50, indicating a potential upside from the current price of $24.02.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

ILMN

Stifel analyst Daniel Arias has reiterated a Buy rating on Illumina, Inc (NASDAQ:ILMN), but lowered the price target to $225 from $265. This comes after Illumina reported better-than-expected Q2 results, with revenue of $1.18 billion, up 1% Y/Y. However, Arias has reduced Q3 revenue estimates to $1.13 billion from $1.16 billion due to slowdown in consumables purchasing amid lower demand in China and instrument transition issues.

Portfolio Pulse from Nabaparna Bhattacharya

August 10, 2023 | 5:55 pm

IPAR

DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on Inter Parfums Inc (NASDAQ:IPAR) with a price target of $187. The company reported 2Q23 sales of $309 million, a 26% increase Y/Y. EPS of $1.09 was above the consensus. The strong performance was driven by both European and U.S. operations. The company raised the FY23 EPS guidance to $4.55 from $4.25 and maintained its sales guidance of $1.30 billion. IPAR shares are trading higher by 0.81% at $136.06.

Portfolio Pulse from Shivani Kumaresan

August 10, 2023 | 5:53 pm

RELI

EF Hutton analyst Michael Albanese has reiterated a 'Buy' rating on Reliance Global Group (NASDAQ:RELI) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 5:52 pm

IKNA

HC Wainwright & Co. analyst Andres Maldonado has reiterated a 'Buy' rating on Ikena Oncology (NASDAQ:IKNA) and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 5:51 pm

TTD

Susquehanna analyst Shyam Patil maintains a positive outlook on Trade Desk (NASDAQ:TTD) and raises the price target from $90 to $105.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 5:51 pm

CBAY

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on CymaBay Therapeutics (NASDAQ:CBAY), maintaining a price target of $19.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 5:50 pm

SMCI

Susquehanna analyst Mehdi Hosseini maintains a Neutral rating on Super Micro Computer (NASDAQ:SMCI) and raises the price target from $90 to $300.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 5:50 pm

ETNB

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on 89bio (NASDAQ:ETNB) and maintained a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 5:49 pm